S. Ghannay Synthesis of (3S,3aS,6aS)-2-acetyl-N-methylhexahydrofuro[3,4-d][1,2]oxazole-3-carboxamide via an oxidative cleavage using m-CPBA. ADME approach

Siwar Ghannay; Maha Aldahlawi; Shomokh Alkhalifa; Fahad Alminderej; Mejdi Snoussi; Wael A. El-Sayed; Adel Kadri; Kaïss Aouadi

View/Download PDF

Buy Reprints

PDF

Translate this page into:

Research Article

1 (

); 154-163

S. Ghannay Synthesis of (3S,3aS,6aS)-2-acetyl-N-methylhexahydrofuro[3,4-d][1,2]oxazole-3-carboxamide via an oxidative cleavage using m-CPBA. ADME approach

Siwar Ghannay, Maha Aldahlawi, Shomokh Alkhalifa, Fahad Alminderej, Mejdi Snoussi, Wael A. El-Sayed, Adel Kadri, Kaïss Aouadi

Received: 2022-10-18, Published: 2022-10-01

Licence

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Disclaimer:
This article was originally published by Qassim University and was migrated to Scientific Scholar after the change of Publisher.

Abstract

Novel (3S,3aS,6aS)-2-acetyl-N-methylhexahydrofuro[3,4-d][1,2]oxazole-3-carboxamide has been synthesized by oxidative cleavage in the presence of m-CPBA in good yield. The analysis of the 1D and 2D NMR spectra unambiguously confirms the stereochemistry of the synthesized product. Bioinformatic study were carried out for the synthesized compound using Swiss ADME program to get insight of its appropriate ADME properties and to avoid the failure of candidate drugs at the clinical stage. Results show that (3S,3aS,6aS)-2-acetyl-N-methylhexahydrofuro[3,4-d][1,2]oxazole-3-carboxamide was within the range set by Lipinski’s rule of five, displayed higher gastrointestinal absorption and inhibition of all CYP isoforms.